The 3D structure of parkin, a ubiquitin ligase involved in a form of Parkinson's disease, shows how REP, by binding RING1 and preventing binding of an E2 ubiquitin-conjugating enzyme, regulates transfer of ubiquitin to a catalytic site in the RING2 domain.
Jean-François Trempe